28
Oct
2025
LABORATORIOS RUBIO,S.A.
Exhibitor at CPHI Frankfurt 2025 stand 3.0A62, Finished Dosage Formulations
About Us
Categories
-
ES -
2015On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
Contact info
-
-
-
Calle Industria 29 , Polígono Industria Comte de Sert , 08755 , Castellbisbal, Barcelona, Spain
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 3.0A62, Finished Dosage Formulations
Products Featured at CPHI Frankfurt 2025
-
Product Liposcale(R) novel advanced test
The Liposcale(R) test is an advanced lipoprotein test based on nuclear magnetic resonance(NMR). From the analysis of serum or plasma samples by NMR, the concentration of cholesteroland triglycerides of the lipoprotein classes VLDL, IDL, LDL and HDL, the concentration ofparticles of the VLDL, LDL and HDL cl... -
Product Methylphenidate Hydrochloride MR
MR - Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 capsules of 10/20/30/40/60 mg. Other packs are also available.
Rubifen LA® is a bioequivalent generic of Ritalin LA® in the treatment of AD... -
Product Guanfacine Hydrochloride
Guanfacine is indicated for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years old) for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Guanfacine must be used as a part of a comprehensive ADHD treatment programm... -
Product Lisdexamfetamine dimesylate
Treatment for Attention Deficit Hyperactivity Disorder (ADHD) -
Product Melatonin 1mg/ml oral solution
Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.
Short-term treatment of jet lag in adults. -
Product Melatonin 2mg prolonged -release
Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.
Modified-release melatonin causes the ... -
Product Tadalafil ODT
Treatment of erectile dysfunction in adult males. In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required.
5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
The product is not indi... -
Product Cholestyramine Resin
Treatment of hypercholesterolaemia: lowering of total and LDL-cholesterol levels in patients with primaryhypercholesterolaemia, including familial hypercholesterolaemia, or secondary as a supplement diet and other treatments, when the response to these measures proves inadequate.Pruritus associated to part... -
Product Calcium Polystyrene Sulphonate
Treatment and prevention of hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
It is indicated for patients treated with dialysis with hyperkalaemia.
Sugar free product. Non-systemic absorption.
... -
Product Hydralazine Hydrochloride
Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents. -
Product Hydroxychloroquine Sulfate
· Rheumatoid Arthritis (joints inflammation)
· Treatment of non-acute and non-complicate Malaria attacks and prevention of Malaria
· &n... -
Product OWLiver® & Liposcale® non-invasive tests
OWLiver ® is a blood test carried out under fasting conditions, which measures a panel of biomarkersall of them lipids. Such biomarkers are a reflection of the amount of fat and inflammationin the liver and, hence, allow to determine the degree of severity of metabolic dysfunction-associatedfatty liver dis... -
Product D-Penicillamine
Hepatolenticular degeneration (Wilson's Disease) in adults, adolescents, and children with 5 years of age and older.
Heavy metals intoxication and Cystinuria in adults, adolescents and children from 5 years of age.
-
Product Methylphenidate Hydrochloride IR
IR - Treatment for children (over 6 years old) and adolescents with Attention Deficit and Hyperactivity Disorder (ADHD).
First Methylphenidate Hydrochloride launched in Spain (1983) with own trademark Rubifen®.
Rubifen® is a bioequivalent generic of Ritalin® in the treatment of ... -
Product Sodium Polystyrene Sulphonate
Treatment and prevention of Hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
Sugar-free product. Non-systemic absorption.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance